Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Cytokinetics shares positive phase 3 results for aficamten in heart disease

Up to one in 500 people in the UK and US are living with hypertrophic cardiomyopathy

- PMLiVE

Madrigal’s liver disease drug Rezdiffra shows promise in compensated MASH cirrhosis

The drug has already been approved in the US to treat patients with non-cirrhotic MASH

- PMLiVE

Roche’s Perjeta-based breast cancer regimen shows sustained survival benefits

Approximately 56,800 new breast cancer cases are diagnosed in the UK every year

- PMLiVE

Johnson & Johnson’s bladder cancer therapy Balversa accepted by SMC

Almost 1,700 people are diagnosed with bladder cancer in Scotland annually

- PMLiVE

Eli Lilly’s Zepbound shows superiority in head-to-head weight loss study

Patients treated with Lilly’s drug achieved an average weight reduction of 20.2%

- PMLiVE

Intersection of Leadership and Advocacy: Driving Change Together for Women

We can’t talk about challenges to women’s reproductive health without acknowledging that we’re living in unprecedented times, say two mission-driven women’s healthcare leaders. Stephanie Sober, MD, MSHP, Global Director, Medical...

Medscape Education

Pharma Chatbots

Smarter, Compliant Engagement: Why Pharma is Warming Up to Chat-Based Solutions

Pharma marketers are embracing chat-based tools to engage HCPs and patients faster, simplify PI sharing, and gain real-time insights — all while staying ABPI and GDPR compliant. When aligned with...

Genetic Digital

- PMLiVE

Takeda’s Adzynma approved by MHRA for rare blood clotting disorder cTTP

The enzyme replacement therapy is now the first treatment approved in the UK for this patient population

- PMLiVE

AstraZeneca announces positive phase 3 results for Imfinzi in high-risk bladder cancer

Around half of NMIBC patients are classed as being high-risk for disease progression or recurrence

- PMLiVE

Novo Nordisk’s GLP-1 drug Wegovy shows early protection against heart disease

Heart and circulatory diseases are responsible for more than 170,000 deaths in the UK every year

- PMLiVE

Transforming Global Market Access: Smarter Resource Management with Local Affiliates – A Live Webinar

Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? Join us live at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Wednesday 21st May, to discover how...

Petauri Evidence

New team members

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links